Stage III NSCLC
7 clinical trials · Condition
| Record | Firm | Date |
|---|---|---|
| A Phase 2 Trial of Almonertinib With Concurrent Radiotherapy in The Treatment of Local Advanced EGFR-mutant NSCLC (NCT04636593) | First People's Hospital of Hangzhou | 2020-08-01 |
| Clinical Trial for Evaluating Efficacy and Safety of PDR001 in Concurrent Plus Consolidation Versus Consolidation Only in Addition to Standard Chemoradiotherapy in Unresectable Stage III NSCLC Patients (PASTURE) (NCT03945227) | Yonsei University | 2019-06-01 |
| Assess the Safety of Immunotherapy Induction With Tremelimumab and Durvalumab Prior to Chemoradiotherapy and/or Resection in the Treatment (NCT04287894) | The Netherlands Cancer Institute | 2018-12-28 |
Track Stage III NSCLC automatically
Every clearance here is in the API, with alerts when new ones post.